Tumor cells circulating in blood are markers for the early detection and prognosis of cancer.
However, detection of these cells is challenging because of their scarcity. In the journal Angewandte Chemie, scientists have now introduced an ultrasensitive method for the direct detection of circulating tumor cells in blood samples. It is based on the amplified, time-resolved fluorescence measurement of luminescent lanthanide ions released from nanoparticles that bind specifically to tumor cells.
Conventional techniques for the detection of circulating tumor cells require complicated enrichment before detection because a sample of 10 million blood cells only contains about one tumor cell. In contrast, the new method developed by a team working with Xiaorong Song, Xueyuan Chen, and Zhuo Chen, at Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fujian Agriculture and Forestry University, and Fujian Cancer Hospital (Fuzhou, Fujian, China), works with no enrichment step and directly detects circulating tumor cells in blood samples. The technique is based on a so-called “dissolution-enhanced time-resolved photoluminescence” and uses fluorescing nanoparticles made of lanthanide europium complex.
First the researchers produced antibodies against the epithelial cell adhesion molecule (EpCAM, which is a glycoprotein that is present in very high numbers on the surfaces of many tumor cells and acts as a diagnostic marker for cancer). These antibodies were applied as a coating in the wells of microplates, causing tumor cells contained in the blood sample to remain stuck deep in the wells as other blood components were removed.
The scientists coated the europium-containing nanoparticles with the same antibodies. This caused large numbers of the nanoparticles, added in solution, to specifically bind to the tumor cells. A subsequently added “developer” dissolved the nanoparticles, releasing myriad europium ions. These were immediately bound and tightly locked up by other components of the developer solution. This resulted in a manifold amplification of the fluorescence.
Another essential advantage of this method is that europium ions are very long-lived fluorophores that continue to fluoresce for several microseconds after excitation with a flash of light. Because the measurements are time-resolved, it is possible to start the measurement with a delay. Background signals caused by the autofluorescence of cell components only continue for a few nanoseconds and fade before the measurement begins. This increases the sensitivity of the measurements, making it possible for the researchers to detect a single tumor cell per microplate well.
Tests with blood samples from cancer patients registered as few as 10 cells per milliliter of blood. Fourteen out of fifteen cancer patients were correctly identified by this new method. The number of tumor cells in the samples correlated strongly with the stage of cancer in each patient.
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- How gene-edited white blood cells are helping fight cancer on November 18, 2019 at 4:14 pm
Training the immune cells to find and kill cancer The first step in making these tumor-killing cells used in the cancer drug trial was to isolate the T-cells – a type of white blood cells that fights ...
- 'Dysbiosis' promotes the onset of colorectal cancer on November 18, 2019 at 10:04 am
as part of a hospital program for clinical cancer research (PHRC-K), led to the development of a non-invasive blood test which identifies the epigenetic phenomenon associated with dysbiosis. The test ...
- Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with Amyloid PET on November 14, 2019 at 4:40 pm
REHOVOT, Israel and NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early ...
- Blood test for deadly eye melanoma on November 14, 2019 at 10:31 am
A simple blood test could soon become the latest monitoring tool for the early detection of melanoma in the eye. University of Queensland scientists have discovered markers in the blood that can ...
- Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with on November 14, 2019 at 8:05 am
which triggers biochemical changes in peripheral blood mononuclear cells and plasma. This proprietary and patented method incorporates biochemistry, physics and signal processing. The company’s two ...
- Science or Fiction: Are Blood Tests Really Accurate? on November 13, 2019 at 6:59 am
There are hopes that painful biopsies for the detection and treatment of cancer could eventually be replaced by blood testing, while separate tests for heart disease and even depression have shown ...
- New blood test could help with early detection of breast cancer on November 6, 2019 at 1:46 pm
Breast Cancer Awareness Month may have just ended, but this month researchers presented a new blood test that may help with early detection of the cancer, which is the most common among women globally ...
- Blood test has potential to provide 5-years-early warning of breast cancer, researchers say on November 6, 2019 at 7:51 am
NOTTINGHAM - A simple blood test may be capable of predicting breast cancer risk in women several years before clinical signs begin to appear, according to a promising study out of Nottingham ...
- New blood test could detect breast cancer up to 5 years before symptoms, say researchers on November 5, 2019 at 11:57 am
And now scientists are developing a new breast cancer screening in the form of a blood test that may be able to detect breast cancer five years before the presentation of clinical symptoms.
- Men born with a genetically high risk of developing prostate cancer 'should have a blood test every year from the age of 40' on November 5, 2019 at 1:28 am
In a study, men with the BRCA2 gene fault who had a blood test were diagnosed at a younger age – an average of 61 years, compared with 64. Experts at the Institute of Cancer Research (ICR), London, ...
via Bing News